Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors
Summary
- Eligibility
- for people ages 3 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Thomas A Hope, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Thomas A Hope, MD
Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He is also the Associate Chair for Business Strategy for Radiology. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Thomas Hope
- ID
- NCT04044937
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Last Updated